Evidence map›Paper›PMID 32550720›Full record

ArticleThe Korean journal of internal medicine2021

The effect of Hericium erinaceum on the prevention of chemically induced experimental colitis in rats.

Ali Durmus, Ilgim Durmus, Omer Bender, Oguzhan Karatepe

Open access · goldAbstract read
In one paragraph

Article in The Korean journal of internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ali DurmusDepartment of Surgery, Nisantasi University, Istanbul, Turkey.
Ilgim DurmusDepartment of Medical Biotechnology, Acibadem University, Istanbul, Turkey.
Omer BenderDepartment of SHMYO (Health Occupation School), Yeni Yuzyil University, Istanbul, Turkey.
Oguzhan KaratepeDepartment of SHMYO (Health Occupation School), Yeni Yuzyil University, Istanbul, Turkey.
Istanbul Yeni Yüzyıl University · TRAcıbadem University · TRİstanbul Nişantaşı Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsThe aim of this study is to investigate the effects of the Hericium erinaceum on an experimental colitis model.

methodsTwenty-four Wistar albino were included in this study. Rats were divided into three groups. Group 1 (n = 8) was sham group. Group 2 is the group of chemically induced by intrarectal administration of trinitrobenzene sulfonic acid (TNBS) resulting in colitis. Group 3 (n = 8) is the group that was treated 7 days before and 7 days after with H. erinaceum resulting in colitis. The activity of colitis was evaluated macroscopically and microscopically in rats. In other words, nitric oxide (NO) levels, malondialdehyde (MDA), interleukin 6 (IL-6), nuclear factor-kappa B (NF-κB) and, tumor necrosis factor-α (TNF-α) in addition to the myeloperoxidasem (MPO) activities was determined.

resultsThe rate of TNBS-induced colitis caused to increase the level of MDA activities meaningfully in the colitis group than the control group. The results indicated that MDA (p = 0.001), NO (p = 0.001), IL-6 (p = 0.001), MPO (p = 0.878), TNF-α (p = 0.001), and NF-κB levels of treatment group decreased in the blood and colon tissues because of the H. erinaceum treatment when compared to the colitis group. H. erinaceum treatment was related to the declining of MDA, NF-κB, NO, IL-6, and TNF-α levels.

conclusionH. erinaceum had a positive effect on the colitis by reducing oxidative damage in blood and tissue.

Indexed as

ColitisHericiumAnimalsColonNF-kappa BRatsRats, WistarTrinitrobenzenesulfonic AcidTumor Necrosis Factor-alphaNF-kappa BTrinitrobenzenesulfonic AcidTumor Necrosis Factor-alphaColitisColonFungal proteinsRats

Identifiers

PMID32550720
PMCPMC8009150
OpenAlexW3035874407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.